Clinical and research tests for C0002895 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 26

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Sickle Cell Disease GENETIX Centro de Investigación en Genética Humana y Reproductiva Colombia	1	1	T Targeted variant analysis
Carrier Screening - Comprehensive Panel (145 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States	185	145	D Deletion/duplication analysis I Microsatellite instability testing (MSI) X Mutation scanning of select exons T Targeted variant analysis
Stroke, Cerebral Hemorrhage, Hemiplegia, and Migraine Panel PreventionGenetics United States	345	159	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
UNITY Carrier Screen BillionToOne United States	16	5	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Red Cell Genotyping Panel Versiti Diagnostic Laboratories Versiti, Inc United States	1	14	T Targeted variant analysis
Sickle Cell Disease Mutation Analysis Baylor Genetics United States	5	1	T Targeted variant analysis
Beta-Thalassemia and Hemoglobinopathy via the HBB Gene PreventionGenetics United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Sickle Cell Anemia, DNA Probe Analysis, Fetus - New York only Quest Diagnostics Nichols Institute San Juan Capistrano United States	2	1	T Targeted variant analysis
Sickle Cell Anemia, DNA Probe Analysis, Fetus Quest Diagnostics Nichols Institute San Juan Capistrano United States	2	1	T Targeted variant analysis
Sickle Cell, Fetal Analysis Integrated Genetics Westborough LabCorp United States	1	1	T Targeted variant analysis
HBB Mutation Analysis Duzen Laboratories Duzen BBAGUAS Turkey	1	1	T Targeted variant analysis
Super Panel Plus NxGen MDx United States	116	117	D Deletion/duplication analysis E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Super Panel 113 NxGen MDx United States	113	115	D Deletion/duplication analysis E Sequence analysis of select exons C Sequence analysis of the entire coding region T Targeted variant analysis
Foresight Myriad Genetics, Inc. United States	112	110	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Weak RhD Analysis Workup Versiti Diagnostic Laboratories Versiti, Inc United States	1	1	T Targeted variant analysis
Partial RhD Analysis Versiti Diagnostic Laboratories Versiti, Inc United States	1	1	T Targeted variant analysis
GeneAware ACMG/ACOG Panel Version 2 (Female) Baylor Genetics United States	19	15	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
GeneAware Basic Panel Version 2 (Female) Baylor Genetics United States	8	7	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
GeneAware Complete Panel Version 2 (Female) Baylor Genetics United States	175	159	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Hb sICKLE, Hb D Punjab, Hb D Iran Institute of Medical Genetics and Genomics Sir Ganga Ram Hospital India	3	1	X Mutation scanning of select exons T Targeted variant analysis

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 26

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.